Scanned by

    Norton

    Norton™ Safe Web

    Trials of Ramucirumab in Gastric Cancer

    Trials of Ramucirumab in Gastric Cancer

    05:45 |
    Download Here

    You Might Also Like:

    Dr Heymach on Updated AEGEAN Data in Resectable NSCLC

    Dr Heymach on Updated AEGEAN Data in Resectable NSCLC

    2:18 |
    Case Study: Treating Papillary Thyroid Cancer

    Case Study: Treating Papillary Thyroid Cancer

    5:12 |
    Management of CLL Progression After Ibrutinib

    Management of CLL Progression After Ibrutinib

    4:07 |
    Trials of Ramucirumab in Gastric Cancer

    Trials of Ramucirumab in Gastric Cancer

    5:46 |
    Information Overload in Oncology: Episode 6

    Information Overload in Oncology: Episode 6

    4:19 |
    Dr Besse on Mechanisms of Acquired Resistance in EGFR+ Advanced NSCLC

    Dr Besse on Mechanisms of Acquired Resistance in EGFR+ Advanced NSCLC

    1:10 |
    Dr Vaz Batista on Treating Patients With HER2+ Breast Cancer and Leptomeningeal Carcinomatosis

    Dr Vaz Batista on Treating Patients With HER2+ Breast Cancer and Leptomeningeal Carcinomatosis

    2:28 |
    Dr Aggarwal on Data for CAN-2409 Plus Valacyclovir and Continued ICIs in NSCLC

    Dr Aggarwal on Data for CAN-2409 Plus Valacyclovir and Continued ICIs in NSCLC

    2:55 |
    Obinutuzumab + Venetoclax for Frontline CLL

    Obinutuzumab + Venetoclax for Frontline CLL

    9:15 |
    Local Control in Metastatic Soft Tissue Sarcoma

    Local Control in Metastatic Soft Tissue Sarcoma

    3:28 |
    OncLive News Network Preview: FDA Approval in Head and Neck Cancer

    OncLive News Network Preview: FDA Approval in Head and Neck Cancer

    0:33 |
    Dr Massarelli on Using Selpercatinib and Pralsetinib in Treating Advanced Non-Small Cell Lung Cancer

    Dr Massarelli on Using Selpercatinib and Pralsetinib in Treating Advanced Non-Small Cell Lung Cancer

    1:32 |
    Dr. Bazhenova on the Value in Attending OncLive State of the Science Summits

    Dr. Bazhenova on the Value in Attending OncLive State of the Science Summits

    1:14 |
    Case Study: HER2-Positive Oligometastatic Breast Cancer

    Case Study: HER2-Positive Oligometastatic Breast Cancer

    3:52 |
    Signs of Progressive Polycythemia Vera

    Signs of Progressive Polycythemia Vera

    6:09 |
    Dr Sands on the Evolving Role of ADCs in SCLC Management

    Dr Sands on the Evolving Role of ADCs in SCLC Management

    2:02 |
    Completion Lymph Node Dissection in Melanoma

    Completion Lymph Node Dissection in Melanoma

    8:00 |
    Dr Sonneveld on the Background of the D-VRd Regimen in Newly Diagnosed Myeloma

    Dr Sonneveld on the Background of the D-VRd Regimen in Newly Diagnosed Myeloma

    2:05 |
    Molecular Testing for AML

    Molecular Testing for AML

    7:31 |
    OncLive News Network On Location: ASCO 2020 Day 2

    OncLive News Network On Location: ASCO 2020 Day 2

    49:52 |